Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2007-11-06
2007-11-06
Nickol, Gary B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S139100, C424S141100, C424S142100, C530S387900, C530S388100, C530S388150
Reexamination Certificate
active
10123215
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5441883 (1995-08-01), Civelli et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5599671 (1997-02-01), Jacobson et al.
Sen, Curr. Opin. Oncol. vol. 12, pp. 82-88, 2000.
Pennica et al. , PNAS USA, vol. 95, pp. 14717-14722, 1998.
Gygi et al. Molecular and Cellular Biology, vol. 19, pp. 1720-1730, 1999.
Ochiishi et al, The Journal of Comparative Neurology, vol. 411, pp. 301-316, 1999.
,Hu et al. (2003, Journal of Proteome Research 2:405-412.
Saito-Hisaminato et al, DNA Res 2002, 9:35-45.
Bustin et al., TRENDS in Molec. Med. 8(6): 269-272, 2002.
Anderson et al., Electrophoresis, vol. 18, pp. 533-537, 1997.
Kawamoto et al., Gene, 1996, vol. 174, pp. 151-158.
Lian et al., 2001, Blood 98:513-524.
Fessler et al., 2002, J. Biol. Chem. 277:31291-31302.
Lucentini (2004) “Gene Association Studies are Typically Wrong”, The Scientist, 18(24): 20.
Haviv, et al. (2002) Molec. Cell. Endocrin., 191: 121-26.
Wu (2001) J. Pathol., 195: 53-65.
Bertucci, et al. (2000) Human Molec. Genet., 9(20): 2981-91.
Greenbaum, et. al. Genome Biology, (2003), vol. 4, Issue 9, Article 117, pp. 117.1-117.8.
Genes VI, Benjamin Lewin, 1997, excert from chapter 29 (includes pp. 847-848).
Dayhoff, Accession No. P—AAU12180, WO 200140466-A2, Pub Date: Jun. 7, 2001, Baker, K.P., et al.
GenBank, Accession No. P—AAS21252, WO 200140466-A2, Pub Date: Jun. 7, 2001, Baker, K.P., et al.
Beà, Silvia, et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphomas”, Cancer Research 61, pp. 2409-2412 (Mar. 15, 2001).
Beer et al, “Gene-expression profiles predict survival of patients with lung adenocarcinoma”, Nature Biomedicine, vol. 98, No. 8, pp. 816-824 (Aug. 2002).
Futcher, B., et al., “A Sampling of the Yeast Proteome”, Molecular and Cellular Biology, vol. 19, No. 11, pp. 7357-7368 (Nov. 1999).
Golub, T.R. et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,”Science 286: 531-537 (Oct. 15, 1999).
Hühnel, Erika, et al., “Expression of the pS2 Gene in Breast Tissues Assessed by pS2-mRNA Analysis and pS2-Protein Radioimmunoassay”, Breast Cancer Research and Treatment, vol. 24, pp. 71-74 (1992).
Janssens, Nico, et al., “Alteration of Frizzled Expression in Renal Cell Carcinoma”, Tumor Biology, vol. 25, pp. 161-171 (2004).
Kammori, Makoto, et al., “Expression of Human Telomerase Reverse Transcriptase Gene and Protein, and of Estrogen and Progesterone Receptors, in Breast Tumors: Preliminary Data from Neo-Adjuvant Chemotherapy”, International Journal of Oncology, vol. 27, No. 5 (Nov. 2005).
Maruyama, Haruhisa, et al., “Id-1 and Id-2 are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis”, American Journal of Pathology, vol. 155, No. 3, pp. 815-822 (Sep. 1999).
Orntoft, T.F. et al., “Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas,” Molecular & Cellular Proteomics 1.1:37-45 (2002).
Papotti, Mauro, et al., “Correlative Immunohistochemical and Reverse Transcriptase Polymerase Chain Reaction Analysis of Somatostatin Receptor Type 2 in Neuroendocrine Tumors of the Lung”, Diagnostic Molecular Pathology, vol. 9, No. 1, pp. 47-57 (2000).
Walmer, David K., et al., “Malignant Transformation of the Human Endometrium is Associated with Overexpression of Lactoferrin Messenger RNA and Protein”, Cancer RESEARCH, vol. 55, No. 5, pp. 1168-1174 (Mar. 1, 1995).
Wen, H.-H. et al., “Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis,” Cancer Research 60: 2716-2722 (May 15, 2000).
Abe, N., et al., “An Increased High-Mobility Group A2 Expression Level is Associated with malignant Phenotype in Pancreatic Exocrine Tissue,”Br J Cancer—89(11):2104-9 (2003) Abstract.
Ando, M., et al., “Selective Apoptosis of Natural Killer-Cell Tumours by I-Asparaginase,”Br J Haematol.,—130(6):860-8 (2005) Abstract.
Aust, G., et al., “Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matrix Metalloproteinase Inhibitor-1 Messenger-RNA and Protein,”Thyroid—7(5):713-24 (1997) Abstract.
Barnes, V.L., et al., “Expression of Embryonic Fibronectin Isoform EIIIA Parallels Alpha-Smooth Muscle Actin in Maturing and Diseased Kidney,”J Histochem Cytochem.—47(6):787-98 (1999) Abstract.
Bea, S., et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphonas,”Cancer Res.—61(6):2409-12 (2001) Abstract.
Blaschke, V., et al., “Rapid Quantitation of Proinflammatory and Chemoattractant Cytokine Expression in Small Tissue Samples and Monocyte-Derived Dentritic Cells: Validation of a New Real-Time RT-PCR Technology,”J Immunol Methods.—246(1-2):79-90 (2000) Abstract.
Buckley, A.R., et al., “Butyrate-Induced Reversal of Dexamethasone Resistance in Autonomouse Rat Nb2 Lymphoma Cells,”Apoptosis.—2(6):518-28 (1997) Abstract.
Caberlotto, L. et al., “Alterations in Neuropeptide Y Levels and Y1 Binding Sites in the Flinders Sensitive Line Rats, A Genetic Animal Model of Depression,”Neurosci Lett.—265(3):191-4 (1999) Abstract.
Caberlotto, L., et al., “Neurokinin 1 Receptor and Relative Abundance of the Short and Long Isoforms in the Human Brain,”Eur J Neurosci.—17(9):1736-46 (2003) Abstract.
Choi, D., et al., “Characterization of Cyclin D2 Expression in Human Endometrium,”J Soc Gynecol Investig.—9(1):41-6 (2002) Abstract.
Couvelard, A., et al., “Human Chorionic Gonadotrophin Beta Expression in Malignant Barrett's Oesophagus,”Virchows Arch.—445(3):279-84 (2004) Abstract.
Dagenais, A., et al., “Downregulation of EnaC Activity and Expression by TNF-Alpha in Alveolar Epithelial Cells,”Am J. Physio Lung Cell Mol Physiol.—286(2):L301-11 (2004) Abstract.
De Boer, C.J., et al., “Involement of the CCNDI Gene in Hairy Cell Leukemia,”Ann Oncol.—7(3):251-6 (1996) Abstract.
Debieve, F., et al., “Inhibin and Activin Production and Subunit Expression in Human Placental Cells Cultured in Vitro,”Mol Hum Reprod.—6(8):743-9 (2000) Abstract.
Dong, Z., et al., “Expression of Membrane-Type Matrix Metalloproteinases 4, 5, and 6 in Mouse Corneas Infected withP. aeruginosa,” Invest Opthalmol Vis Sci—42(13):3223- (2001) Abstract.
Duchrow, M., et al., “Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR),”Cancer Invest.—19(6):588-96 (2001) Abstract.
Dyer, J., et al., “Molecular Characterization of Carbohydrate Digestion and Absorption in Equine Small Intestine,”Equine Vet J.—34(4):349-58 (2002) Abstract.
Egwuagu, C.E., et al., “Suppressors of Cytokine Signaling Proteins are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance,”J Immunol.—168(7):3181-7 (2002) Abstract.
El-Ghrably, I.A., et al., “Intravitreal Invading Cells Contribute to Vitreal Cytokine Milieu in Proliferative Vitreor
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Smith Victoria
Wood William I.
Barnes Elizabeth M.
Basi Nirmal S.
Dreger Ginger R.
Genentech Inc.
Kresnak Mark T.
LandOfFree
Antibodies against PRO4406 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against PRO4406, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against PRO4406 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3849360